Both in Surgical Instruments
Cytosorbents vs Femasys
Over the past year CTSO returned −71.2% and FEMY returned −89.5%; their daily moves had a correlation of 0.02.
CTSO −71.2% FEMY −89.5%Growth of $1, one year, split-adjusted
| Metric | CTSO | FEMY |
|---|---|---|
| Price | $4.56 | $1.44 |
| Market cap | $14.4M | $12.1M |
| Today | +0.44% | +2.86% |
| 1 month | +15.2% | −30.8% |
| 6 months | −60.0% | −84.1% |
| Year to date | −64.3% | −87.5% |
| 1 year | −70.8% | −89.0% |
| Revenue growth (YoY) | +0.2% | −18.9% |
| Gross margin | 73.2% | 57.1% |
| Net margin | −45.9% | −1346.8% |
| P/E (TTM) | — | — |
| Price / sales | 0.4× | 5.2× |
| Net cash | -$12.8M | -$2.1M |
| Dividend yield | — | — |
| Volatility (60d) | 881.4% | 91.2% |
| Short % of float | 0.2% | 2.4% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).